Article
Impact of YAQ001 on the gut microbiome, permeability and markers of systemic inflammation in patients with cirrhosis
2025-12-09
Abstract excerpt
<h4>Background and aims</h4> YAQ001 is a novel, highly engineered, non-absorbable, gut-restricted, multiporous, carbon bead adsorbent. Pre-clinical studies and a clinical trial confirmed its therapeutic potential and safety in patients with cirrhosis. The aims of this sub study were to evaluate the effect of YAQ001 on the gut microbiome and its association with biomarkers of gut permeability and systemic inflamma...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5227af47-efb3-5c12-8373-56a67e4ef281
- DOI
- 10.64898/2025.12.01.25341286
